Hayes et al., developed a modified, peroxisome-targeting, catalase derivative, enzyme-catalase-SKL, which was loaded into EVs through a co-incubation procedure, and the system was tested against multiple neurodegenerative diseases such as AD and PD. The gene discussed is CAT; the disease is Alzheimer disease.